An approach to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indica....
Work for Abide Therapeutics? Take ownership of your company’s profile and submit the latest details about your company to keep the investors, strategics, and service providers using our database up-to-date on the work being done at your company.
